European Biotech Acquisition Corp. – NASDAQ:EBAC

Financial Health
0
1
2
3
4
5
6
7
8
9

European Biotech Acquisition Corp. stock price monthly change

+10.14%
month

European Biotech Acquisition Corp. stock price quarterly change

+11.79%
quarter

European Biotech Acquisition Corp. stock price yearly change

+15.01%
year

European Biotech Acquisition Corp. key metrics

Market Cap
 183.50M
Enterprise value
 N/A
P/E
 559.5
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 1.17
PEG ratio
 -5.96
EPS
 0.19
Revenue
 N/A
EBITDA
 -5.97M
Income
 3.50M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

European Biotech Acquisition Corp. stock price history

European Biotech Acquisition Corp. stock forecast

European Biotech Acquisition Corp. financial statements

Profit Margin

European Biotech Acquisition Corp. (NASDAQ:EBAC): Profit margin
Mar 2022 0 3.28M
Jun 2022 0 773.73K
Sep 2022 0 215.23K
Dec 2022 0 -770.30K
EBAC income statement history

Debt to Assets

European Biotech Acquisition Corp. (NASDAQ:EBAC): Debt to assets
Mar 2022 128517658 6.14M 4.78%
Jun 2022 128225132 5.65M 4.41%
Sep 2022 128701644 6.52M 5.07%
Dec 2022 129752775 8.54M 6.59%
EBAC balance sheet history

Cash Flow

European Biotech Acquisition Corp. (NASDAQ:EBAC): Cash Flow
Mar 2022 -149.99K 0 0
Jun 2022 -410.18K 0 0
Sep 2022 -35.47K 0 0
Dec 2022 80.85K 0 -45K
EBAC cash flow history

European Biotech Acquisition Corp. other data

Frequently Asked Questions (FAQ)

  • When is European Biotech Acquisition Corp.'s next earnings date?

    Unfortunately, European Biotech Acquisition Corp.'s (EBAC) next earnings date is currently unknown.

  • Does European Biotech Acquisition Corp. pay dividends?

    No, European Biotech Acquisition Corp. does not pay dividends.

  • How much money does European Biotech Acquisition Corp. make?

    European Biotech Acquisition Corp. has a market capitalization of 183.50M.

  • What is European Biotech Acquisition Corp.'s stock symbol?

    European Biotech Acquisition Corp. is traded on the NASDAQ under the ticker symbol "EBAC".

  • What is European Biotech Acquisition Corp.'s primary industry?

    Company operates in the Financial Services sector and Shell Companies industry.

  • How do i buy shares of European Biotech Acquisition Corp.?

    Shares of European Biotech Acquisition Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When European Biotech Acquisition Corp. went public?

    European Biotech Acquisition Corp. is publicly traded company for more then 4 years since IPO on 11 May 2021.

  • What is European Biotech Acquisition Corp.'s official website?

    The official website for European Biotech Acquisition Corp. is lspvc.com.

  • How can i contact European Biotech Acquisition Corp.?

    European Biotech Acquisition Corp. can be reached via phone at +31 20 664 5500.

European Biotech Acquisition Corp. company profile:

European Biotech Acquisition Corp.

lspvc.com
Exchange:

NASDAQ

Full time employees:

0

Industry:

Shell Companies

Sector:

Financial Services

European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands.

+31 20 664 5500
Johannes Vermeerplein 9
Amsterdam, 1071 DV

CIK: 0001841258
ISIN: KYG3167F1028
CUSIP: G3167F102